SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IDPH--Positive preliminary results for pivotal trial of ID
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1762 27 0 IDPH
Emcee:  Roudy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
187 Hello Brad, I am very appreciative that you found the time to post this eveninI. Luttichuys-12/8/1996
186 Hi Bennett, I just returned from ASH conference and am very pleased with what Brad C. Dunlap-12/8/1996
185 Hello Don, Just taking a break from studies and dropped in on the thread. I. Luttichuys-12/8/1996
184 Doug, If you have not read the posts in this thread, then I would suggest thatRoudy-12/8/1996
183 I just got involved with this company and understand that a major announcement Doug Robinson-12/8/1996
182 One other thing-part of the stipulation of advancement to Phase III testing wasRoger Cranwill-12/7/1996
181 Hello Roger, I did not recall Zenyaku Kogyo's assistance in the area of pI. Luttichuys-12/7/1996
180 Julie-I may be naive, but I believe IDEC moved to a larger site for the expressRoger Cranwill-12/7/1996
179 Hello Julie, I hope that what scientific background I may have (which is not aI. Luttichuys-12/7/1996
178 Building a commerical production facility will be expensive, excess of 100 millJulie Suk-12/7/1996
177 Hello Roger, Your point is, as you say, a VERY powerful reason IDEC will be prI. Luttichuys-12/6/1996
176 Bennett-Your point about alternate therapies for cancer treatment is one of theRoger Cranwill-12/6/1996
175 Hello Julie, You have a very interesting background and I bet could act a specI. Luttichuys-12/6/1996
174 Hello Rick, I think as well that this is a very exciting approach to CA therapI. Luttichuys-12/6/1996
173 Brad, I find the thought of CD20 as a front line defense very exciting. I woulRick Costantino-12/6/1996
172 Brad: If C2B8 were approved by 9/97, IDEC should have a full quarter of sales Don Cheng-12/6/1996
171 Hello Bennett Idec is very knowledable on making humanized antibodies at largeJulie Suk-12/6/1996
170 Hi Don, I don't have his full blown report here at my house other then a coBrad C. Dunlap-12/5/1996
169 Brad: Can you tell me if Eric Hecht's latest earning estimates on IDEC hasDon Cheng-12/5/1996
168 Hello Julie, Welcome to the thread. In answer to your question, I have not peI. Luttichuys-12/5/1996
167 Hello Brad, IDEC was quite strong today. Eric Hecht's position is interesI. Luttichuys-12/5/1996
166 Hello Bennet and Rick I fully agree with your assessment of Idec. I can not prJulie Suk-12/5/1996
165 Hi Bennett, Another great day for Idec and the biotechs. At the ASH conference Brad C. Dunlap-12/5/1996
164 Hello Rick, I think your strategy is sound. I am not at this point anticipatiI. Luttichuys-12/5/1996
163 Hello Bennett et al. As we have discussed before, buying IDEC on dips is a gooRick Costantino-12/5/1996
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News